We create bold solutions to challenge AFib. You rely on technology bold enough not to compromise between efficiency and accuracy. With this technology that boldly redefines the EP Lab, you can elevate your practice and meet today’s challenges.
Revolutionize high-density cardiac mapping with the EnSite™ X EP System and EnSite™ Omnipolar Technology (OT) and EnSite™ OT Near Field – a next generation 3D mapping platform created to give you a POWERFUL, RELIABLE and EFFICIENT user experience for every procedure.
Introduction to EnSite X EP System and EnSite OT
Unleash the power of the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ and EnSite OT to revolutionize high density mapping.
AFib is a growing crisis in Electrophysiology (EP). This condition affects more than 37 million people.2 We create bold solutions to challenge AFib. This is a suite technology that boldly redefines the EP Lab. Clinical support that elevates your practice to meet today’s challenges. It is a partnership to drive impact and grow the EP community.
Trust Model and Location Accuracy Over Time
Overcome stability challenges with changes in patient management and EP lab environment variables, using the EnSite™ VoXel Mode.
Cleaner maps with automatic removal of outliers - your map is ready faster with EnSite™ X Software Version 2 and outlier filtering that reduces editing time.
Get in and out of your lab faster with software and hardware designed for efficiency.
*EnSite™ OT captures true signals independent of catheter orientation relative to the wavefront.
**Every signal can be defined as any signal seen on the RAI window recorded by the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ when the map polarity is set to omnipolar.
***Based on the system measuring metal distortion and inhibiting data collection if distortion exceeds set threshold.
MAT-2009688 v6.0
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?
MAT-2305078 v1.0